IN8bio, Inc. (INAB) NASDAQ
1.61
-0.12(-6.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.61
-0.12(-6.94%)
Currency In USD
| Market Cap | 10.24M |
| Enterprise Value | -14.07M |
| P/E Ratio | -0.37 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.31 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.72 |
| Return On Equity | -0.96 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.5M |
| EBITDA | -17.36M |
| Net Income | -19.44M |
| Diluted EPS | -4.44 |
| Total Cash | 21.94M |
| Total Cash/Share | 5.02 |
| Total Debt | 2.35M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 10.5 |
| Book Value Per Share | 5.21 |
| 52-Week Change | -59.85 |
| 52-Week High | 4.17 |
| 52-Week Low | 1.17 |
| Moving Average 50 Days | 1.54 |
| Moving Average 200 Days | 1.88 |
| Average Volume | 68,784 |
| Shares Outstanding | 4.64M |
| % Held by Institutions | 85.79 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | June 06, 2025 |